Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers
Tumor genetics guides patient selection for many new therapies, and cell culture studies have demonstrated that specific mutations can promote metabolic phenotypes. However, whether tissue context defines cancer dependence on specific metabolic pathways is unknown. Kras activation and Trp53 deletion...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Other Authors: | , |
Format: | Article |
Language: | English |
Published: |
American Association for the Advancement of Science (AAAS),
2018-06-25T15:28:29Z.
|
Subjects: | |
Online Access: | Get fulltext |